Brochure
11 Nov 2023
Ethics Approval - Phase III Efficacy Clinical Trial
PDF 231 kB
Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial
Content provided by our supplier
Chanelle McCoy Health
-
Country/Region:Ireland
-
On CPHI since:2020
-
Certificates:1
-
Employees:1 - 24
Company types
Primary activities
Other Content from Chanelle McCoy Health (1)
-
News UK Food Standards Agency recognises Pureis with first-ever Positive Safety Assessment for CBD
This article takes an in depth look at the regulatory process that CBD products must go through for UK sale as a ‘Novel Foods’ supplement, and why it’s important that consumers choose products that have been given a thumbs up for safety by the Food Standards Agency (FSA).